Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed COO
Inv. presentation
ATOSSA THERAPEUTICS, INC. (ATOS) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/09/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/04/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/15/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/15/2021 SC 13G CVI Investments, Inc. reports a 5.3% stake in Atossa Therapeutics, Inc.
01/14/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/28/2020 SC 13G INTRACOASTAL CAPITAL, LLC reports a 4.9% stake in Atossa Therapeutics, Inc.
12/18/2020 SC 13G CVI Investments, Inc. reports a 8.5% stake in Atossa Therapeutics, Inc.
11/09/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
11/03/2017 SC 13G L1 Capital Global Opportunities Master Fund, Ltd. reports a 9% stake in Atossa Genetics, Inc.
10/31/2017 SC 13G Empery Asset Management, LP reports a 9% stake in Atossa Genetics Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy